GreenLight Biosciences Total Current Liabilities

GreenLight Biosciences (GRNA) currently reports a total current liabilities of $31M as of March 2023. That compares with $30M in the prior-year period — up 5.6% year over year. Use the charts on this page to explore GreenLight Biosciences's total current liabilities history and peer comparisons.

GreenLight Biosciences's total current liabilities increased from $30M to $31M — a 5.6% year-over-year increase (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GreenLight Biosciences reported $31M in total current liabilities as of March 2023. That compares with $30M in the prior-year period — up 5.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $31M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GreenLight Biosciences, and consider following GRNA for alerts when major investors trade the stock.